95 | A PHASE 1/2 STUDY TO EVALUATE THE SAFETY AND EFFICACY OF XNW5004, A SELECTIVE EZH2 INHIBITOR, IN SUBJECTS WITH RELAPSED/ REFRACTORY NON‐HODGKIN LYMPHOMA

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	W. Zheng, Z. Qian, K. Zhou, Q. Cai, K. Zhong, H. Jing, J. Wu, X. Xing, Y. Cao, X. Zhang, D. Zhou, X. Yan, Z. Zhang, X. Liang, L. Su, W. Yu, H. He, Y. Huang, M. Le, J. Qi, L. Qiu
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Hematological Oncology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Similar Items